EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Retrospective Identification and Quantitative Image Analysis of the ICAP Nuclear Pattern AC ‐30 in Antinuclear Antibody Testing

Changmeng Wu, Wenhan Du iD, Weidong Chen, Juan He, Linlin Xu, Yu Li iD

Journal of Clinical Laboratory Analysis · 2026-07 · 40 (13)

DOI: 10.1002/jcla.70249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, online erschienen am 22.05.2026. Verfasst von Changmeng Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Antibodies, Antinuclear, Cell Nucleus, Image Processing, Computer-Assisted. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The International Consensus on ANA Patterns (ICAP) recently codified the AC‐30 nuclear pattern, characterized by fine speckled nuclear texture and metaphase chromatin staining. Although formally recognized, its clinical significance remains unclear. Quantitative methods and objective outcome measures for characterizing AC‐30 have not been established.

Methods

A retrospective analysis was conducted using archived HEp‐2 ANA images. AC‐30 was defined by unanimous scoring from three blinded experts. AC‐1 and AC‐2 served as comparator sets. Clinical diagnoses and serological data were retrieved from hospital records. Pixel classification was performed using ilastik, and per‐nucleus intensity features were extracted with CellProfiler. Image‐level separation was assessed by partitioning nuclei into high‐ and low‐intensity groups via Isolation Forest. Statistical comparisons used Welch's t ‐tests and Spearman's rank correlation.

Results

The AC‐30 group included 183 images (AC‐1, n = 183; AC‐2, n = 207). Within AC‐30, 57.4% had non‐AID or unknown diagnoses, 26.8% had other autoimmune diseases, and 15.8% had ANA‐associated rheumatic disease (AARD). In ENA‐negative AC‐30, AARD accounted for 7.7% (6/78), compared to 18.3% (21/115) in ENA‐negative AC‐2. RA accounted for 16.9% (31/183) in AC‐30, consistent across ENA strata. AC‐30 displayed lower per‐nucleus intensities than AC‐2 (all p < 0.0001) and reduced per‐image ΔMaxIntensity (0.177 vs. 0.252, p < 0.0001), while ΔMeanIntensity was similar (0.068 vs. 0.067, p = 0.549).

Conclusions

AC‐30 is quantitatively dimmer than AC‐2, with reduced nuclear brightness and peak‐intensity separation. In this retrospective cohort, ENA‐negative AC‐30 was associated with fewer AARD cases. RA accounted for ~17% of AC‐30, and anti‐CCP and RF remained informative markers. The ilastik–CellProfiler workflow enables auditable ANA quantification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntinuclearCell NucleusImage Processing, Computer-AssistedHumansRetrospective StudiesAutoimmune Diseases

Stichwörter der Autor:innen

CellProfilerHEp‐2antinuclear antibodyilastikimage quantificationinternational consensus on antinuclear antibody patternspattern 30rheumatoid arthritis

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
  • Department of Rheumatology and Immunology, Peking University Shenzhen Hospital, Shenzhen, China.
  • Shenzhen Key Laboratory of Immunity and Inflammatory Diseases, Shenzhen, China.
  • Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, China.

ORCID-Profile: Wenhan Du, Yu Li

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Shenzhen Science and Technology Program
  • Shenzhen High-level Hospital Construction Fund
  • Peking University Shenzhen Hospital Scientific Research Fund
  • Medical Scientific Research Foundation of Guangdong Province

Zitieren

APA

Wu, C., Du, W., Chen, W., He, J., Xu, L., & Li, Y. (2026). Retrospective Identification and Quantitative Image Analysis of the ICAP Nuclear Pattern AC ‐30 in Antinuclear Antibody Testing. Journal of Clinical Laboratory Analysis, 40(13). https://doi.org/10.1002/jcla.70249

Vancouver

Wu C, Du W, Chen W, He J, Xu L, Li Y. Retrospective Identification and Quantitative Image Analysis of the ICAP Nuclear Pattern AC ‐30 in Antinuclear Antibody Testing. Journal of Clinical Laboratory Analysis. 2026;40(13). doi:10.1002/jcla.70249

BibTeX
@article{Wu2026,
  author = {Wu, Changmeng and Du, Wenhan and Chen, Weidong and He, Juan and Xu, Linlin and Li, Yu},
  title = {Retrospective Identification and Quantitative Image Analysis of the ICAP Nuclear Pattern AC ‐30 in Antinuclear Antibody Testing},
  journal = {Journal of Clinical Laboratory Analysis},
  year = {2026},
  volume = {40},
  number = {13},
  doi = {10.1002/jcla.70249}
}
Kostenlos starten →